Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Gynecologic 1

Conditions

Multiple Myeloma 155Lymphoma 20Recurrence 17Neoplasms 12Hematologic Neoplasms 11Neoplasms, Plasma Cell 9Lymphoma, Non-Hodgkin 9Immunoglobulin Light-chain Amyloidosis 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Leukemia, Myeloid, Acute 5Hodgkin Disease 5Smoldering Multiple Myeloma 4Prostatic Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Plasma Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Breast Neoplasms 4Ovarian Neoplasms 3Melanoma 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3Cytokine Release Syndrome 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × Plasma cell × 30 days × Clear all
NCT07609576 2026-05-27

Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.

Infanta Leonor University Hospital

Recruiting
350 enrolled
Plasma cell

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡